Total Funding
61
42
Total FundingPost-IPO Equity raised
Growth Score
-7 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
90647
Celldex is a clinical stage company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases.
- Chip Catlin: Senior Vice President and Chief Financial Officer
Thomas Davis: CMO, SVP Clinical DevelopmentPast Role: Medarex, Senior Director
About the Company
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to
improve the lives of patients with inflammatory diseases and many forms of cancer.
